Pages
Products
CAG-ChR2-YFP AAV (Serotype 8)

CAG-ChR2-YFP AAV (Serotype 8)

Cat.No. :  AAV00102Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 8 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00102Z
Description CAG-ChR2-YFP AAV (Serotype 8) is the serotype 8 AAV which express Channelrhodopsin-2 under CAG promoter with YFP tag. Channelrhodopsins are a subfamily of opsin proteins that function as light-gated ion channels and very useful for many bioengineering and neuroscience applications such as photostimulation of neurons for probing of neural circuits. Using a Yellow Fluorescent Protein (YFP) tagged ChR2, light-stimulated axons and synapses can be identified in intact brain tissue. This is useful to study the molecular events during the induction of synaptic plasticity. ChR2 has also been used to map long-range connections from one side of the brain to the other, and to map the spatial location of specific inputs on the dendritic tree of individual neurons.
Serotype AAV Serotype 8
Target Gene CAG-ChR2-YFP
Product Type Adeno-associated virus
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

Adeno-associated virus (AAV) is a non-enveloped parvovirus with a single-stranded DNA genome of approximately 4.7 kb that is a common backbone for recombinant viral vectors. AAV is non-pathogenic, has relatively low immunogenicity, and AAV vectors can be produced in large quantities with high purity. AAV is able to transduce post-mitotic cells for long periods of time, with gene expression observed for more than 6 years in primates. These factors have led to the widespread use of AAV vectors in the nervous system, where they can transduce targeted brain regions locally via stereotactic injection, diffusely transduce large brain volumes via intraventricular or intravenous administration, or transfer genes into primary cultures of neurons and glial cells. A large number of evolutionarily diverse AAV serotypes have been identified. When compared directly after brain injection, these serotypes exhibit different neuronal cell tropisms, transduction intensities, and gene expression profiles. While some serotypes transduce only within the normal range of diffusion, others also transduce cells at considerable distances from the injection site. This distal transduction results from axonal transport of the intact vector, either by uptake in the axon terminal, retrograde transport to the cell body, and subsequent transduction, or by uptake in projection neurons, anterograde transport along axonal projections, secretion from the axon terminal, and transduction in second-order neurons.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Reliable Results

I’ve been utilizing the CAG-ChR2-YFP AAV (Serotype 8) in our neuroscience research, and the results have been outstanding. The viral vector consistently delivers excellent expression of ChR2-YFP, allowing for precise manipulation and observation of neuronal activity.

United States

12/10/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction